Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News


November 30, 2012
Youth Make Up 25% of New HIV Cases, Most Don’t Know Their Status
Accounting for a quarter of all new HIV infections in 2010, 60 percent of young people between the ages of 13 and 24 are unaware of their serostatus.
November 29, 2012
An Almost Normal Life Expectancy for People With HIV?
People with HIV who don't inject drugs and aren't coinfected with hepatitis may enjoy life spans close to normal if their success on antiretrovirals endures.
November 28, 2012
High-Dose Vitamins Don’t Fight HIV and Can Raise Liver Levels
A large study has found that high doses of multivitamin supplements fail to combat HIV and may raise liver levels in those also taking antiretrovirals. 
November 26, 2012
Liver Cancer Spikes Among Spanish Coinfected With HIV, Hepatitis
Spanish researchers have sounded the alarm that rates of liver cancer are rising dramatically among people with HIV, solely as a result of viral hepatitis.
November 21, 2012
Clusters of Young, Recently Infected Gay Men Driving Danish HIV Cases
The Danish HIV epidemic’s main driver is young, newly infected gay men.  Those who test positive for later do not play a major role in spreading the virus.
November 20, 2012
Stribild Is Comparable to Other Single-Tablet Combo Therapies
Stribild—the new quad combo pills—is non-inferior to both Atripla and to ritonavir-boosted atazanavir plus Truvada in first-time treatment takers.
November 19, 2012
Single-Tablet Complera Combo Regimen Proves Comparable to Atripla
Complera proved to be comparable to, and in some cases more effective than, Atripla in a study comparing the two antiretroviral therapy combo pill regimens among treatment-naive people with HIV.
November 16, 2012
Integrase Inhibitor Dolutegravir Shows Promise in Drug-Resistant HIV
Phase III data show that the integrase inhibitor dolutegravir fully suppressed viral loads among 63 percent of people with multi drug-resistant HIV.
November 15, 2012
Hep C Protease Inhibitor Incivek Is Safe, Effective for HIV Coinfection
People coinfected with HIV and hepatitis C virus experience high hepatitis cure rates from an Incivek (telaprevir)?based triple combination therapy.
HIV-Positive Women May Benefit From HPV Vaccine
HIV-positive women may benefit from the HPV vaccine, especially those who have not been exposed to the higher-risk forms of HPV.
November 14, 2012
Mental Decline Among HIV Population Largely Unrelated to Virus
Neurocognitive impairment among HIV-positive adults appears to be related to the same factors associated with mental decline in the general population.
November 13, 2012
Adolescents Born With HIV Engage in High-Risk Behaviors
New research has found that perinatally-infected adolescents with HIV are engaging in high-risk behaviors.
November 12, 2012
Lubes May Damage Cells, but Do Not Raise HIV Risk
While many personal lubricants may irritate vaginal and rectal tissues, they do not increase the risk of HIV transmission—at least in test tube experiments.
November 09, 2012
African Study Bolsters Argument to Begin HIV Therapy Early
A new African study has shown that there is significantly higher risk of death for those who start antiretroviral therapy with a CD4 count below 500.
November 08, 2012
Condoms Treated With Silver Nanoparticles Inactivate HIV and Herpes
When added to condoms, microscopic nanoparticles of silver may create a powerful safety net against HIV and sexually transmitted infections. 
November 07, 2012
Class Lines and Race Strikingly Divide AIDS Death Rates
The dramatic reduction in AIDS death rates during the modern antiretroviral (ARV) era has tended to elude minorities and those of lower socioeconomic status.
November 06, 2012
HIV Meds and Alcohol Not a Toxic Mix, Yet Many Skip Doses While Drinking
Nearly half of all HIV-positive people who both take antiretrovirals and drink alcohol report skipping or stopping their meds while drinking.
November 05, 2012
Methadone Linked to Drop in HIV Rates Among Injection Drug Users
A major research review has found that injection drug users on methadone treatment are 54 percent less likely to contract HIV. 
November 02, 2012
Brief Treatment Interruptions for Cure Studies Are Safe, Well-Tolerated
Short treatment interruptions of HIV antiretroviral regimens are both safe and well-tolerated, which is good news for scientists pursuing functional cures. 
November 01, 2012
Once-Daily Tenofovir Prodrug Combo Pill as Effective as Stribild
Gilead Sciences announced its once-daily quadruple-agent combination pill, based on a prodrug formulation of tenofovir, is as effective as Stribild.
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ



Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dversescott
    Baltimore
    Maryland


    romanticseattle
    Tacoma
    Washington


    hollywoodvers1
    Los Angeles
    California


    blaze11212
    brooklyn
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.